GHRP-6 Protocol: How to Cycle It, Timing & What to Expect

Protocol snapshot

• Typical cycle length: 8 to 12 weeks, followed by a 4 to 6 week off-cycle break; some experienced protocols extend to 16 weeks, though most sources advise against this to avoid receptor desensitization
• Frequency: Three times daily (morning, midday, bedtime), spaced at least 3 to 4 hours apart; beginners often start once or twice daily before stepping up
• Common delivery routes: Subcutaneous injection only
• Key timing notes: Inject on an empty stomach, at least 2 to 3 hours after a meal and 30 minutes before eating. Carbohydrates and dietary fat near the injection window significantly blunt the GH secretory response. The bedtime dose is the highest-priority window because it amplifies the natural nocturnal GH surge.

Who This Protocol Is For

GHRP-6 draws two broad groups of users. The first is people primarily chasing body composition changes: leaning out while building or preserving lean mass, with the understanding that GH-mediated results accumulate over months rather than weeks. The second is people focused on recovery and tissue repair, drawn by preclinical research showing GHRP-6's effects on collagen synthesis, joint support, and post-exercise recovery.

Within those two camps, goal specifics vary considerably. Some users run GHRP-6 as a standalone GH secretagogue. Others pair it with a GHRH analog like CJC-1295 (also called Mod GRF 1-29), which amplifies the GH pulse that GHRP-6 triggers. A smaller group runs it primarily for sleep quality and recovery, leaning on the bedtime dose as the priority window.

Experience level matters for this compound more than for most. GHRP-6's most immediate pharmacological effect is intense appetite stimulation via ghrelin receptor agonism, and first-time users routinely underestimate it. Someone who has not experienced that appetite spike before, or who is managing body weight carefully, needs to build up to the standard frequency gradually rather than stepping in at full doses from day one.

Delivery method here is straightforward: GHRP-6 is subcutaneous only. There is no oral, nasal, or topical route with meaningful pharmacological effect for this compound. If needle aversion is a significant concern, it shapes the protocol decision before anything else.

How Is a GHRP-6 Cycle Structured?

A GHRP-6 cycle runs 8 to 12 weeks at its core, with 12 weeks being the most commonly cited duration across practitioner protocols and community logs. The cycle uses a titration approach rather than a sharp loading-phase distinction: start conservatively in the first two weeks to gauge how the body handles the appetite stimulation and overall response, step the dose per injection upward through weeks three and four, and then hold at the target level through the end of the cycle. Think of it less like a sprint-and-coast and more like a car merging onto a highway: you build to cruising speed before holding it.

After the active cycle, a 4 to 6 week off-cycle break is the standard. The rationale is receptor biology: sustained GHSR-1a stimulation leads to receptor downregulation, meaning the ghrelin receptors that GHRP-6 activates gradually become less responsive without a rest period. The off-cycle break allows receptor sensitivity to restore and lets the HPA axis normalize before the next cycle begins.

Some protocols extend the cycle to 16 weeks, but most sources flag this as increasing the risk of receptor desensitization without proportional benefit. The 8 to 12 week window is where practitioner protocols and community experience converge as the practical sweet spot.

How Your Dose Is Determined

What moves a GHRP-6 dose:

• Your goal: Body composition goals are typically associated with protocols that work up to the higher end of the injection range across the titration weeks, because the GH release needed to drive fat loss and lean mass changes over a multi-month timeline is substantial. Recovery-focused goals often land in the lower-to-mid range and sometimes prioritize fewer daily injections, with the bedtime dose as the critical window.
• Experience level: First-time users consistently start at a lower per-injection amount and often at just one or two daily injections during the first week to assess the appetite response before stepping up. More experienced users who know how their body handles the hunger spike build through the titration phases with more confidence.
• Delivery route: GHRP-6 is subcutaneous only. Because the route does not vary, what shifts is the site rotation discipline: injecting the same location repeatedly causes tissue irritation, so rotating between the lower abdomen and flanks is the standard approach.
• Individual response: GHRP-6's appetite stimulation is the clearest signal that the peptide is active, but the magnitude varies meaningfully between individuals. Someone highly sensitive to the appetite effect may find that the lower end of the range produces adequate GH response with more manageable hunger. Cortisol and IGF-1 (insulin-like growth factor 1, a hormone the liver releases in response to GH that drives tissue growth and repair) levels, measured at baseline and at the 6-week mark, give an objective read on how the cycle is actually performing.

One principle worth understanding: research suggests there is a saturation point per injection for GHRP-6. Above a certain threshold, increases primarily intensify side effects, particularly appetite stimulation and cortisol elevation, rather than producing proportionally greater GH output. This is why dose-per-injection increases through the titration phase are moderate and deliberate. The protocol is designed to find the level where the GH response is meaningful without the appetite and hormonal side effects becoming unmanageable.

Your dose should not be a guess. The MyPeptidePal Protocol Creator takes your specific goal, how your appetite response develops across the titration weeks, and whether you are running GHRP-6 alone or paired with a GHRH analog and builds your GHRP-6 protocol: your dose, your cycle, and your timing.

Get your protocol at mypeptidepal.ai

How Often Do You Take GHRP-6?

Three times daily is the standard frequency for GHRP-6, with a morning, midday, and bedtime pattern. The spacing rule is firm: injections need at least 3 to 4 hours between them. This is not arbitrary scheduling preference. GHRP-6 has an approximate half-life of 2.5 hours, and the GH response it triggers is inherently pulsatile. Spacing injections far enough apart allows each one to produce a discrete GH pulse rather than stacking doses on top of a still-active response and losing the pulsatile pattern the pituitary is designed to work with.

The empty-stomach requirement is as important as the timing. Blood glucose elevation from carbohydrates and circulating free fatty acids from dietary fat both significantly blunt the GH secretory response. The practical rule is to inject at least 2 to 3 hours after a meal and then wait 30 minutes before eating. This makes the bedtime dose the most manageable window for many users since the previous meal is typically furthest behind them, and it also positions the injection to amplify the body's natural nocturnal GH surge during deep sleep.

Beginners frequently start at once daily (bedtime only) for the first week to assess the appetite spike before adding additional daily injections. The frequency is dictated by the compound's pharmacokinetics: the half-life is too short to sustain meaningful GH elevation between injections at once-daily dosing for most goals. Users who train often work an injection into the 30-minute window before a session to align the GH peak, which arrives roughly 30 to 60 minutes post-injection, with training.

Some protocols use twice daily for a transition period before moving to the full three-times-daily pattern, which is a sensible bridge for anyone whose appetite response in the first week feels difficult to manage.

Loading and Maintenance Phases

GHRP-6 does not follow a sharp loading-and-maintenance structure. There is no separate loading dose that differs from the maintenance dose, and there is no front-loading period where a higher amount is used to saturate the system faster.

What exists instead is a titration structure built around the ghrelin receptor's sensitivity and the appetite response. The first two weeks serve as a calibration period: the protocol starts at the lowest per-injection amount and frequency to establish how appetite stimulation lands and whether early side effects such as water retention or mild nausea are manageable. The compound is working and producing GH pulses from the first injection; the priority in these early weeks is finding the floor of an effective response before increasing.

Weeks three and four step the per-injection amount upward as familiarity with the hunger response builds. From week five through the end of the cycle, most protocols hold at the target level with the dose staying consistent across that final stretch. There is no tapering down at the end of a GHRP-6 cycle. The cycle concludes at the target level, followed by the off-cycle break.

For users running GHRP-6 alongside a GHRH analog, both peptides are administered in the same injection window at comparable amounts. The GHRH analog amplifies the GH pulse while GHRP-6 triggers the release, and the empty-stomach timing requirement applies equally to both.

Off-Cycle Considerations

The off-cycle break after a GHRP-6 cycle is not optional from a receptor biology standpoint. Sustained stimulation of GHSR-1a receptors without adequate rest leads to downregulation: the receptors become progressively less responsive to the compound, GH release per injection diminishes, and the cost-to-benefit ratio of continuing shifts unfavorably.

The standard is a 4 to 6 week off-cycle break between cycles. During this period, receptor sensitivity is restored and the HPA axis (the hormonal system that governs your body's stress and cortisol response) is allowed to normalize. Measuring cortisol and IGF-1 before the next cycle begins gives an objective baseline rather than relying on subjective feel to decide when to resume. If cortisol remains elevated or IGF-1 has not returned toward baseline, extending the off-cycle period is the appropriate approach.

One practical reality of the off-cycle phase is appetite normalization. Users who have been running GHRP-6's potent appetite stimulation for 8 to 12 weeks often find that hunger returns to baseline fairly quickly after stopping, which serves as a useful signal that the ghrelin receptor stimulation is subsiding.

What to Expect Week by Week

• Week 1 to 2: The most immediate and reliable signal that GHRP-6 is active is appetite stimulation. Most users describe intense hunger arriving 20 to 30 minutes post-injection. Sleep quality often improves within the first two weeks, particularly with the bedtime dose, as the nocturnal GH surge is amplified. Mild water retention may begin by days three to five. Body composition changes are not expected at this stage.
• Week 3 to 4: IGF-1 becomes measurable by days three to five of the cycle and continues rising as the titration steps the dose upward. Improved recovery from training, reduced post-exercise soreness, and increased joint comfort are commonly reported in this window. Improved skin hydration is noted by some users.
• Week 5 to 8: Body composition differences may start to become visible for users whose training and nutrition are optimized. Water retention that appeared early often stabilizes or resolves. Recovery continues to feel faster and more complete.
• Beyond 8 weeks: The cumulative effects of sustained GH and IGF-1 elevation become the dominant story. Muscles feel fuller, skin and scar quality improvements accumulate, and the body composition arc becomes more apparent.

These are commonly reported ranges drawn from research and real-world protocol data, not guarantees. Individual results vary by how faithfully the empty-stomach timing is maintained, the frequency pattern used, consistency across the cycle, and individual hormone response. A well-run GHRP-6 cycle followed through to 12 weeks with disciplined timing commonly produces a meaningful combination of outcomes: leaner body composition, noticeably faster post-training recovery, improved sleep quality, and skin and joint changes that accumulate across the whole cycle. Users who report the best results consistently describe the same pattern: they treated the empty-stomach timing as a hard constraint rather than a rough guideline.

Common Protocol Mistakes

Eating near the injection window. The single most common reason a GHRP-6 protocol underperforms is poor meal timing relative to injections. Carbohydrates raise blood glucose and dietary fat raises circulating free fatty acids; both significantly blunt the GH secretory response. If injections land in the middle of post-meal digestion rather than on a genuinely empty stomach, the GH pulse is substantially reduced with every dose. Treat the empty-stomach rule as a hard constraint, not a guideline.

Skipping the titration and starting at full frequency. First-time GHRP-6 users who step in at three-times-daily from day one frequently find the appetite stimulation overwhelming and either mismanage nutrition around it or stop the cycle early. The titration structure exists specifically to allow the appetite response to be assessed and managed before stepping up.

Confusing micrograms with insulin units. This is the most dangerous mechanical error in GHRP-6 administration. At a standard reconstituted concentration, a given mcg amount corresponds to a small number of units on an insulin syringe, not a matching number of units. The number you draw in units is not the same as the number of micrograms you are targeting. Always verify the drawn volume against your intended mcg amount before injecting. Your personalized dose and the corresponding drawn volume are built in the MyPeptidePal Protocol Creator.

Running the cycle without a rest period. Continuous GHRP-6 use without an off-cycle break leads to GHSR-1a receptor downregulation. The protocol becomes progressively less effective, but side effects such as appetite stimulation and cortisol elevation do not necessarily follow the same decline. The 4 to 6 week break is the mechanism by which the next cycle works.

Injecting without rotating sites. Repeatedly injecting the same subcutaneous site causes tissue irritation and eventually affects absorption consistency. Rotating between the lower abdomen and flanks on a daily basis prevents localized irritation.

Sourcing from unverifiable suppliers. GHRP-6 is a research compound and is not regulated for human use in the same way pharmaceutical products are. Products from suppliers without verified manufacturing standards and independent third-party testing carry meaningful risks, including contamination, incorrect concentration, and degraded peptide. The FDA has flagged compounded peptide preparations as carrying risks of immunogenicity due to peptide aggregation and impurities. Cloudy liquid or floating particles in a vial are immediate disqualifying signs; never inject from a vial in that condition.

GHRP-6 is not FDA-approved for any human therapeutic indication and is classified as a research compound. Its use in competitive sport is banned under WADA anti-doping regulations.

Frequently Asked Questions

How long is a typical GHRP-6 cycle?

The standard GHRP-6 cycle runs 8 to 12 weeks, with 12 weeks being the most commonly cited duration across practitioner protocols and community logs. Some experienced protocols extend to 16 weeks, though most sources recommend against this to limit receptor desensitization. Cycle length is personalized based on your goal and experience level in the MyPeptidePal Protocol Creator.

How often do you take GHRP-6?

Three times daily is the standard frequency: morning, midday, and bedtime, spaced at least 3 to 4 hours apart. This pattern aligns with the compound's short half-life and produces discrete GH pulses rather than continuous stimulation. Beginners often start at once or twice daily before stepping up to the full three-times-daily pattern.

Does GHRP-6 need a loading phase?

Not in the traditional sense. GHRP-6 uses a titration approach rather than a distinct loading phase where a higher dose is used upfront. The per-injection amount steps up gradually across the first four weeks to allow the appetite response to be assessed and managed, not to front-load the system at a higher level.

Do you need to cycle off GHRP-6?

Yes. The 4 to 6 week off-cycle break after each GHRP-6 cycle is necessary to restore GHSR-1a receptor sensitivity and allow HPA axis normalization. Continuous use without a rest period leads to progressive receptor downregulation, meaning the compound becomes less effective at producing GH pulses over time.

Why is appetite stimulation so strong with GHRP-6?

GHRP-6 activates the ghrelin receptor (GHSR-1a), and ghrelin is the body's primary hunger hormone. Binding that receptor directly produces intense appetite stimulation as a pharmacological effect rather than an incidental side effect. Most users report the hunger spike arriving 20 to 30 minutes post-injection, peaking sharply, and then subsiding. This is the most reliable early indicator that the compound is biologically active, and the titration structure of the protocol is specifically designed to allow users to build familiarity with it before stepping up to full frequency.

Can GHRP-6 be stacked with other peptides?

The most commonly cited combination is GHRP-6 paired with a GHRH analog such as CJC-1295, which amplifies the GH pulse that GHRP-6 triggers. Both are administered in the same injection window, and the empty-stomach timing rules govern both. Users also report pairing GHRP-6 with MK-677, though that combination is associated with more pronounced water retention.

Disclaimer

This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. MyPeptidePal is not a medical provider. Always consult a qualified healthcare professional before starting, modifying, or stopping any health protocol, supplement regimen, or therapeutic intervention.

Sources

The information in this guide is drawn from the MyPeptidePal knowledge base, which brings together published research, clinical data, and documented real-world protocols for GHRP-6 in one place.